Edgestream Partners, L.P. Invitae Corp Transaction History

Edgestream Partners, L.P.

  • $2.05 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$1.2 - $2.73 $627,358 - $1.43 Million
-522,799 Reduced 66.55%
262,782 $354,000
Q4 2022

Feb 13, 2023
SELL
$1.71 - $3.61 $836,826 - $1.77 Million
-489,372 Reduced 38.38%
785,581 $1.46 Million
Q3 2022

Nov 14, 2022
BUY
$1.9 - $8.63 $2.42 Million - $11 Million
1,274,953 New
1,274,953 $3.14 Million

Others Institutions Holding NVTA

# of Institutions
38
Shares Held
2.12M
Call Options Held
0
Put Options Held
0
View Full List

About Invitae Corp

NVTA Quotes by TradingView
  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Edgestream Partners, L.P. Portfolio

Follow Edgestream Partners, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Edgestream Partners, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Edgestream Partners, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email